Xan Pharma Labs Private Limited

Pharmaceutical trading and resale company based in Chennai, India.

2012 | Chennai, Tamil Nadu (India) | Active
Last Updated: December 30, 2024

Xan Pharma Labs Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 12 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024

About Xan Pharma Labs

Xan Pharma Labs Private Limited (XPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 December 2012 and has a history of 12 years and one month. Its registered office is in Chennai, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Lakshminarayanan Sunetha and Chandrasekharan serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51900TN2012PTC089086

  • Company No.

    089086

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    19 Dec 2012

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

Who are the key members and board of directors at Xan Pharma Labs?

Board Members (2)

Name Designation Appointment Date Status
Lakshminarayanan Sunetha Country flag representing In Director 19-Dec-2012 Current
Chandrasekharan Country flag representing In Director 19-Dec-2012 Current

Financial Performance of Xan Pharma Labs.

Xan Pharma Labs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Xan Pharma Labs?

In 2017, Xan Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Xan Pharma Labs?

Unlock and access historical data on people associated with Xan Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xan Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xan Pharma Labs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Xan Pharma Labs

Recent activity within the organization

  • Annual General Meeting

    Xan Pharma Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Xan Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

    31 Mar 2024

  • Director Appointment

    Lakshminarayanan Sunetha was appointed as a Director was appointed as a Director on 19 Dec 2012 & has been associated with this company since 12 years 1 month .

    19 Dec 2012

  • Director Appointment

    Chandrasekharan was appointed as a Director was appointed as a Director on 19 Dec 2012 & has been associated with this company since 12 years 1 month .

    19 Dec 2012

  • Company Incorporation

    Xan Pharma Labs Private Limited was registered on 19 Dec 2012 with Roc Chennai & aged 12 years 1 month as per MCA records.

    19 Dec 2012

Frequently asked questions

  • Xan Pharma Labs Private Limited was incorporated on 19 Dec 2012.

  • The authorized share capital of Xan Pharma Labs Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Currently 2 directors are associated with Xan Pharma Labs Private Limited.

    • Lakshminarayanan Sunetha
    • Chandrasekharan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Xan Pharma Labs Private Limited is 78/16 Soorappa Street, Triplicane India, Chennai, Tamil Nadu, 600005.

  • The corporate identification number (CIN) of Xan Pharma Labs Private Limited is U51900TN2012PTC089086 and the company number is 089086 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Xan Pharma Labs Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Pharmaceutical Retailers & Distributors